Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Chris Turner"'
Autor:
Anne-Marie Slowther, Jenny Harlock, Celia J Bernstein, Katie Bruce, Karin Eli, Caroline J Huxley, Jacqui Lovell, Claire Mann, Angela Noufaily, Sophie Rees, Julia Walsh, Chris Bain, Hazel Blanchard, Jeremy Dale, Paramjit Gill, Claire A Hawkes, Gavin D Perkins, Rachel Spencer, Chris Turner, Amy M Russell, Martin Underwood, Frances Griffiths
Publikováno v:
Health and Social Care Delivery Research, Vol 12, Iss 42 (2024)
Background Emergency care treatment plans provide recommendations about treatment, including cardiopulmonary resuscitation, to be considered in emergency medical situations. In 2016, the Resuscitation Council United Kingdom developed a standardised e
Externí odkaz:
https://doaj.org/article/962e9738f9fc4f84be225f617aca04fc
Publikováno v:
Applied Artificial Intelligence, Vol 38, Iss 1 (2024)
ABSTRACTScholars often recommend incorporating context into the design of an explainable artificial intelligence (XAI) model in order to ensure successful real-world adoption. However, contemporary literature has so far failed to delve into the detai
Externí odkaz:
https://doaj.org/article/32570d5b02354313b4cb239f0d38a184
Autor:
Huihui Luo, Emil K. Gustavsson, Hannah Macpherson, Natalia Dominik, Kristina Zhelcheska, Kylie Montgomery, Claire Anderson, Wai Yan Yau, Stephanie Efthymiou, Chris Turner, Michael DeTure, Dennis W. Dickson, Keith A. Josephs, Tamas Revesz, Tammaryn Lashley, Glenda Halliday, Dominic B. Rowe, Emily McCann, Ian Blair, Andrew J. Lees, Pentti J. Tienari, Anu Suomalainen, Laura Molina-Porcel, Gabor G. Kovacs, Ellen Gelpi, John Hardy, Matti J. Haltia, Arianna Tucci, Zane Jaunmuktane, Mina Ryten, Henry Houlden, Zhongbo Chen
Publikováno v:
Acta Neuropathologica Communications, Vol 12, Iss 1, Pp 1-6 (2024)
Externí odkaz:
https://doaj.org/article/66ce109f71ec44af9981960c060d30a1
Autor:
Andrea C. Kakouri, Demetris Koutalianos, Andrie Koutsoulidou, Anastasis Oulas, Marios Tomazou, Nikoletta Nikolenko, Chris Turner, Andreas Roos, Anna Lusakowska, Katarzyna Janiszewska, George K. Papadimas, Constantinos Papadopoulos, Evangelia Kararizou, Eleni Zamba Papanicolaou, Grainne Gorman, Hanns Lochmüller, George M. Spyrou, Leonidas A. Phylactou
Publikováno v:
RNA Biology, Vol 19, Iss 1, Pp 507-518 (2022)
Muscular dystrophies are a group of rare and severe inherited disorders mainly affecting the muscle tissue. Duchene Muscular Dystrophy, Myotonic Dystrophy types 1 and 2, Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy are so
Externí odkaz:
https://doaj.org/article/fce9b866c9544801aef48904f2cb8776
Autor:
Demetris Koutalianos, Andrie Koutsoulidou, Chrystalla Mytidou, Andrea C. Kakouri, Anastasis Oulas, Marios Tomazou, Tassos C. Kyriakides, Marianna Prokopi, Konstantinos Kapnisis, Nikoletta Nikolenko, Chris Turner, Anna Lusakowska, Katarzyna Janiszewska, George K. Papadimas, Constantinos Papadopoulos, Evangelia Kararizou, George M. Spyrou, Geneviève Gourdon, Eleni Zamba Papanicolaou, Grainne Gorman, Andreas Anayiotos, Hanns Lochmüller, Leonidas A. Phylactou
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 169-183 (2021)
Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, primarily characterized by muscle wasting and weakness. Many biomarkers already exist in the rapidly developing biomarker research field that aim to improve patients
Externí odkaz:
https://doaj.org/article/0df8908873d4446eb6c45e3b522382e8
Autor:
Chris Turner, John Oyekan
Publikováno v:
Applied Sciences, Vol 13, Iss 8, p 4912 (2023)
This research examines the opportunities provided by advances in digital manufacturing technologies for the provision of products designed to meet the needs of an individual consumer. The ability to co-create products with customers could enable mass
Externí odkaz:
https://doaj.org/article/d8dfc38f1ad543f69760c07fa681473f
Publikováno v:
BMC Medical Ethics, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Medical ethics has recently seen a drive away from multiple prescriptive approaches, where physicians are inundated with guidelines and principles, towards alternative, less deontological perspectives. This represents a clear call
Externí odkaz:
https://doaj.org/article/bf83f9ef6cfb4b64a88638a1757b8552
Autor:
Zhongbo Chen, Wai Yan Yau, Zane Jaunmuktane, Arianna Tucci, Prasanth Sivakumar, Sarah A. Gagliano Taliun, Chris Turner, Stephanie Efthymiou, Kristina Ibáñez, Roisin Sullivan, Farah Bibi, Alkyoni Athanasiou‐Fragkouli, Thomas Bourinaris, David Zhang, Tamas Revesz, Tammaryn Lashley, Michael DeTure, Dennis W. Dickson, Keith A. Josephs, Ellen Gelpi, Gabor G. Kovacs, Glenda Halliday, Dominic B. Rowe, Ian Blair, Pentti J. Tienari, Anu Suomalainen, Nick C. Fox, Nicholas W. Wood, Andrew J. Lees, Matti J. Haltia, Genomics England Research Consortium, John Hardy, Mina Ryten, Jana Vandrovcova, Henry Houlden
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 9, Pp 1716-1725 (2020)
Abstract Neuronal intranuclear inclusion disease (NIID) is a clinically heterogeneous neurodegenerative condition characterized by pathological intranuclear eosinophilic inclusions. A CGG repeat expansion in NOTCH2NLC was recently identified to be as
Externí odkaz:
https://doaj.org/article/bd65c1e21b3a43b093ee1ae9f5b87933
Autor:
Aura Cecilia Jimenez‐Moreno, Nikoletta Nikolenko, Marie Kierkegaard, Alasdair P. Blain, Jane Newman, Charlotte Massey, Dionne Moat, Jas Sodhi, Antonio Atalaia, Grainne S. Gorman, Chris Turner, Hanns Lochmüller
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 6, Iss 8, Pp 1487-1497 (2019)
Abstract Objectives Defining clinically relevant outcome measures for myotonic dystrophy type 1 (DM1) that can be valid and feasible for different phenotypes has proven problematic. The Outcome Measures for Myotonic Dystrophy (OMMYD) group proposed a
Externí odkaz:
https://doaj.org/article/bd7d09a45e034484a1b9cd9ae66d164c
Autor:
Oyekan, Chris Turner, John
Publikováno v:
Sustainability; Volume 15; Issue 13; Pages: 10169
This paper provides a classification of manufacturing types in terms of new technological tools provided in the Industry 5.0 framework. The manufacturing types agile, holonic, flexible and reconfigurable benefit from and are potentially changed by In